Milla A - Search Results

1

Biweekly docetaxel and vinorelbine as first-line chemotherapy in metastatic breast cancer.

Mayordomo JI, Milla A, Morales S, Yubero A, Lorenzo A, Baena JM, Modolell A, Sanz J, Illarramendi J, Garcia MJ, Machengs I, Burrilo MA, Tres A. Mayordomo JI, et al. Among authors: milla a. Clin Breast Cancer. 2004 Jun;5(2):131-5. doi: 10.3816/cbc.2004.n.017. Clin Breast Cancer. 2004. PMID: 15245617

2

A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

Espinosa E, Zamora P, Millá A, Morales S, Molina R, Mira M, González Barón M; Oncopaz Cooperative Group. Espinosa E, et al. Among authors: milla a. Head Neck. 2002 Dec;24(12):1054-9. doi: 10.1002/hed.10172. Head Neck. 2002. PMID: 12454943 Clinical Trial.

3

High-dose ifosfamide and mesna in advanced breast cancer. A phase II study.

Sanchiz F, Milla A. Sanchiz F, et al. Among authors: milla a. Cancer Chemother Pharmacol. 1990;26 Suppl:S91-2. doi: 10.1007/BF00685432. Cancer Chemother Pharmacol. 1990. PMID: 2112057

4

Tegafur-uracil (UFT) plus folinic acid in advanced rectal cancer.

Sanchiz F, Milla A. Sanchiz F, et al. Among authors: milla a. Jpn J Clin Oncol. 1994 Dec;24(6):322-6. Jpn J Clin Oncol. 1994. PMID: 7830337 Clinical Trial.

5

VP-16 plus cyclophosphamide in the treatment of advanced lung cancer.

Estape J, Milla A, Agusti A, Sanchez-Lloret J, Santabarbara P, Rozman C. Estape J, et al. Among authors: milla a. Cancer. 1983 Feb 1;51(3):385-9. doi: 10.1002/1097-0142(19830201)51:3<385::aid-cncr2820510305>3.0.co;2-k. Cancer. 1983. PMID: 6295601

6

A randomized trial of mitomycin/ifosfamide/cisplatin preoperative chemotherapy plus surgery versus surgery alone in stage IIIA non-small cell lung cancer.

Rosell R, Maestre J, Font A, Moreno I, Molina F, Milla A, Gómez-Codina J, Camps C. Rosell R, et al. Among authors: milla a. Semin Oncol. 1994 Jun;21(3 Suppl 4):28-33. Semin Oncol. 1994. PMID: 8209274 Clinical Trial.

7

VP16-213 and cyclophosphamide in advanced breast cancer. A phase II study.

Estapé J, Cirera L, Millá A, Doncel F. Estapé J, et al. Among authors: milla a. Cancer Chemother Pharmacol. 1983;10(3):154-7. doi: 10.1007/BF00255751. Cancer Chemother Pharmacol. 1983. PMID: 6861258

8

A randomised study comparing granulocyte-colony stimulating factor (G-CSF) with G-CSF plus thymostimulin in the treatment of haematological toxicity in patients with advanced breast cancer after high dose mitoxantrone therapy.

Sanchiz F, Milla A. Sanchiz F, et al. Among authors: milla a. Eur J Cancer. 1996 Jan;32A(1):52-6. doi: 10.1016/0959-8049(95)00459-9. Eur J Cancer. 1996. PMID: 8695241 Clinical Trial.

9

Prevention of radioinduced cystitis by orgotein: a randomized study.

Sanchiz F, Millá A, Artola N, Julià JC, Moya LM, Pedro A, Vila A. Sanchiz F, et al. Among authors: milla a. Anticancer Res. 1996 Jul-Aug;16(4A):2025-8. Anticancer Res. 1996. PMID: 8712737 Clinical Trial.

10

Bone marrow recuperation by AM3 in breast cancer patients submitted to aggressive adjuvant treatment. A preliminary report.

Millá A, Sanchiz F, Sada G, Villarrubia VG. Millá A, et al. Anticancer Res. 1986 Jul-Aug;6(4):865-8. Anticancer Res. 1986. PMID: 3752963 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters